rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Colin Hill

Director

Company insider

Files Form 4 as: Director, Fulcrum Therapeutics; Director, Ppd; Director, Biotelemetry.

In numbers

Trades disclosed
18
Buys
0
Sells
1
Bought
$0
Sold
$54K
Companies
3
Companies where not an officer
3
First trade
4 May 2016
Last trade
30 Jun 2026
Last filed
2 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
FULC Fulcrum TherapeuticsDirector · Biotechnology · last 30 Jun 20260 buys · 0 sells
PpdDirector · last 8 Dec 20210 buys · 1 sell
BiotelemetryDirector · last 9 Feb 20210 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
30 Jun 2026filed 2 Jul 2026FULC Fulcrum Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—32,000 at $0.00filing
30 Jun 2026filed 2 Jul 2026FULC Fulcrum Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—32,000 at $0.00filing
26 Jun 2025filed 30 Jun 2025FULC Fulcrum Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—36,000 at $0.00filing
17 Jun 2024filed 18 Jun 2024FULC Fulcrum Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—60,000 at $0.00filing
8 Dec 2021filed 8 Dec 2021PpdSEC FORM 4 Code D$776K16,330 at $47.50filing
23 Apr 2021filed 27 Apr 2021PpdSEC FORM 4 Code A—2,164 at $0.00filing
9 Feb 2021filed 11 Feb 2021BiotelemetrySEC FORM 4 Code D$1.6M21,654 at $72.00filing
21 Sep 2020filed 23 Sep 2020PpdSEC FORM 4 Sold$54K1,722 at $31.28filing
13 May 2020filed 15 May 2020PpdSEC FORM 4 Code A—3,728 at $0.00filing
11 May 2020filed 13 May 2020BiotelemetrySEC FORM 4 Code A—2,863 at $0.00filing
3 May 2020filed 13 May 2020BiotelemetrySEC FORM 4 Code F$86519 at $45.51filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Code D—12,160filing
10 Feb 2020filed 12 Feb 2020PpdSEC FORM 4 Code A—12,160filing
6 May 2019filed 7 May 2019BiotelemetrySEC FORM 4 Code F$1,32225 at $52.87filing
3 May 2019filed 7 May 2019BiotelemetrySEC FORM 4 Code A—2,424 at $0.00filing
4 May 2018filed 8 May 2018BiotelemetrySEC FORM 4 Code A—3,191 at $0.00filing
12 May 2017filed 16 May 2017BioTelemetrySEC FORM 4 Code A—2,842 at $0.00filing
4 May 2016filed 6 May 2016BioTelemetrySEC FORM 4 Code A—10,378 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Kevin Tang10% owner · 10% owner at Fulcrum Therapeutics, filing Form 4 there in the last year
Katina DortonDirector · Director at Fulcrum Therapeutics, filing Form 4 there in the last year
James A. GeraghtyDirector · Director at Fulcrum Therapeutics, filing Form 4 there in the last year
Robert J. GouldDirector · Director at Fulcrum Therapeutics, filing Form 4 there in the last year
Rachel K. KingDirector · Director at Fulcrum Therapeutics, filing Form 4 there in the last year